Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 6/20 | 0.50 |
| ▸ | LAP3 | P28838 | 2/20 | 0.43 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.42 |
| ▸ | GGPS1 | O95749 | 2/20 | 0.41 |
| ▸ | S1PR2 | O95136 | 5/20 | 0.40 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.40 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.40 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.40 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.37 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7794700 | 0.80 | FDPS (0.50) | FDPSLAP3SMPD1GGPS1LPAR2 | |
| SCHEMBL8973818 | 0.78 | FDPS (0.48) | FDPSGGPS1LPAR2LPAR3 | |
| SCHEMBL8973757 | 0.78 | FDPS (0.48) | FDPSGGPS1LPAR2LPAR3 | |
| SCHEMBL6234653 | 0.77 | FDPS (0.44) | FDPSLAP3SMPD1S1PR2S1PR1 | |
| SCHEMBL8469648 | 0.76 | LPAR3 (0.50) | FDPSGGPS1LPAR2LPAR3 | |
| SCHEMBL8468195 | 0.76 | LPAR3 (0.50) | FDPSGGPS1LPAR2LPAR3 | |
| SCHEMBL649060 | 0.76 | LPAR3 (0.50) | FDPSGGPS1LPAR2LPAR3 | |
| SCHEMBL8467723 | 0.76 | LPAR3 (0.50) | FDPSGGPS1LPAR2LPAR3 | |
| SCHEMBL12555231 | 0.76 | LPAR3 (0.50) | FDPSGGPS1LPAR2LPAR3 | |
| SCHEMBL8469031 | 0.76 | LPAR3 (0.50) | FDPSGGPS1LPAR2LPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3450440-B1 | BENZOTRIAZOLE DERIVATIVE, MANUFACTURING METHOD THEREFOR AND USE THEREOF | CHINA PETROLEUM & CHEM CORP (CN) | 2022-05-18 | — | — | EP | disclosed |
| US-10822359-B2 | Benzotriazole derivative, preparation process and the use thereof | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2020-11-03 | — | — | US | disclosed |
| US-20190106446-A1 | BENZOTRIAZOLE DERIVATIVE, PREPARATION PROCESS AND THE USE THEREOF | RESEARCH INSTITUTE OF PETROLEUM PROCESSING, SINOPEC (CN) | 2019-04-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10822359-B2 | Benzotriazole derivative, preparation process and the use thereof | SULT1A1, TAF5, TAF1 | FDPS 4163/4885LAP3 4740/4885SMPD1 4841/4885 |
| US-20190106446-A1 | BENZOTRIAZOLE DERIVATIVE, PREPARATION PROCESS AND THE USE THEREOF | SULT1A1, TAF5, TAF1 | FDPS 4163/4885LAP3 4740/4885SMPD1 4841/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.